AbbVie Inc (ABBV)
203.55
-0.32
(-0.16%)
USD |
NYSE |
Nov 01, 16:00
203.53
-0.02
(-0.01%)
After-Hours: 20:00
AbbVie Total Liabilities (Quarterly): 135.12B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 135.12B |
| March 31, 2024 | 140.83B |
| December 31, 2023 | 124.31B |
| September 30, 2023 | 124.09B |
| June 30, 2023 | 122.47B |
| March 31, 2023 | 121.24B |
| December 31, 2022 | 121.52B |
| September 30, 2022 | 125.30B |
| June 30, 2022 | 128.50B |
| March 31, 2022 | 126.90B |
| December 31, 2021 | 131.09B |
| September 30, 2021 | 135.28B |
| June 30, 2021 | 135.38B |
| March 31, 2021 | 136.77B |
| December 31, 2020 | 137.47B |
| September 30, 2020 | 134.33B |
| June 30, 2020 | 134.80B |
| March 31, 2020 | 98.61B |
| December 31, 2019 | 97.29B |
| September 30, 2019 | 67.67B |
| June 30, 2019 | 65.71B |
| March 31, 2019 | 64.60B |
| December 31, 2018 | 67.80B |
| September 30, 2018 | 69.08B |
| June 30, 2018 | 65.02B |
| Date | Value |
|---|---|
| March 31, 2018 | 65.79B |
| December 31, 2017 | 65.69B |
| September 30, 2017 | 62.15B |
| June 30, 2017 | 60.98B |
| March 31, 2017 | 60.67B |
| December 31, 2016 | 61.46B |
| September 30, 2016 | 60.16B |
| June 30, 2016 | 61.57B |
| March 31, 2016 | 49.08B |
| December 31, 2015 | 49.10B |
| September 30, 2015 | 49.97B |
| June 30, 2015 | 48.35B |
| March 31, 2015 | 25.32B |
| December 31, 2014 | 25.77B |
| September 30, 2014 | 23.81B |
| June 30, 2014 | 23.83B |
| March 31, 2014 | 23.96B |
| December 31, 2013 | 24.71B |
| September 30, 2013 | 24.68B |
| June 30, 2013 | 24.35B |
| March 31, 2013 | 24.21B |
| December 31, 2012 | 23.64B |
| September 30, 2012 | 7.061B |
| June 30, 2012 | 6.204B |
| March 31, 2012 | 6.911B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
97.29B
Minimum
Dec 2019
140.83B
Maximum
Mar 2024
126.91B
Average
128.50B
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 83.36B |
| Johnson & Johnson | 108.13B |
| Eli Lilly and Co | 61.29B |
| Merck & Co Inc | 68.98B |
| Pfizer Inc | 128.22B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 141.94B |
| Shareholders Equity (Quarterly) | 6.778B |
| Debt to Equity Ratio | 10.42 |
| Current Ratio | 0.8068 |
| Net Debt Paydown Yield | 3.50% |